Keyphrases
Cholesterol
66%
Cachexia
54%
Niemann-Pick C1-like 1 (NPC1L1)
49%
Endoplasmic Reticulum
34%
Niemann-Pick
34%
N-terminal Domain
31%
Lysosome
30%
Tumor
27%
Cancer Cachexia
27%
Weight Loss
23%
Plasma Membrane
21%
Non-small Cell Lung Cancer (NSCLC)
20%
Egress
15%
Handoff
15%
Chronic Use
13%
Lipid Bilayer
13%
Cholesterol-binding Protein
13%
Stage IV NSCLC
13%
C Cells
13%
Cancer-associated Weight Loss
13%
Socio-economic Characteristics
13%
Ethnic Characteristics
13%
Survival Outcomes
13%
Continuous Transport
13%
Surface Residue
13%
Socioeconomic Status
13%
Bidirectional Transfer
13%
Leukemia Inhibitory Factor
13%
Niemann-Pick Type C
13%
Movement Control
13%
Anthrolysin O
13%
Liver Kinase B1 (LKB1)
13%
Ostreolysin A
13%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
13%
Racial-ethnic
13%
Leptin
13%
Cyclodextrin
13%
Intracellular Cholesterol Transport
13%
STK11
13%
Gain-of-function mutation
13%
Single nucleus
13%
Molecular Pathways
13%
Muscle Atrophy
13%
NPC2
11%
Membrane Binding
10%
Sphingomyelin
9%
Perfringolysin O
7%
Adipose Tissue
6%
Human Non-small Cell Lung Cancer
6%
Myogenin
6%
Biochemistry, Genetics and Molecular Biology
Lysosome
46%
Cell Membrane
42%
Adipocyte
31%
N-Terminus
29%
Amino Acids
28%
NPC1
26%
Lipolysis
26%
Cholesterol Transport
23%
Oxysterol
21%
STAT3
19%
Binding Protein
18%
Leukemia Inhibitory Factor
17%
Cytokine
17%
Sphingomyelin
13%
Leukemia Inhibitory Factor Receptor
13%
Lipid Bilayer
13%
Sterol
13%
Transcription
13%
Membrane Protein
13%
Leptin
13%
Sterol Regulatory Element-Binding Protein
13%
Cyclodextrin
13%
Cholesterol Level
10%
Lipoprotein
10%
Interleukin-6
9%
Cholesterol Synthesis
7%
Fibroblast
7%
Sphingomyelin Phosphodiesterase
7%
Acid Sphingomyelinase
7%
Acyltransferase
7%
N-Acetyltransferase
7%
Acyl-CoA
7%
Binding Site
7%
Mouse
7%
Endocytosis
7%
Eicosanoid Receptor
7%
Body Weight
5%
Lipid
5%
Low-Density Lipoprotein
5%
Medicine and Dentistry
Cachexia
100%
Malignant Neoplasm
47%
Gastrointestinal Cancer
29%
Lung Cancer
27%
Neoplasm
21%
Symptomatic Treatment
16%
Non-Small Cell Lung Cancer
15%
Primary Tumor
15%
Prevalence
14%
Cell Membrane
14%
Disease
14%
Radiation Therapy
14%
Nonalcoholic Fatty Liver
13%
Experimental Steatohepatitis
13%
Non Small Cell Lung Cancer
13%
Hepatocyte
13%
Nonsteroid Antiinflammatory Agent
13%
Socioeconomic Status
13%
Endoplasmic reticulum
13%
Glucocorticoid
13%
Hepatocellular Carcinoma
13%
Muscle Atrophy
13%
Cholesterol Transport
11%
Odds Ratio
9%
Cancer Diagnosis
9%
Drug Therapy
6%
Positron Emission Tomography
6%
Myogenin
6%
Logistic Regression Analysis
6%
Colorectal Cancer
5%
Survival Analysis
5%
Hazard Ratio
5%
